Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. scores highest on Torque (74) and lowest on Price (13). Its PosiPenta is 45.05 out of 100, around the middle of similar companies.
On the Penta Grid this week, Trevi Therapeutics, Inc. is Grid #381 of 836 in the Healthcare sector in United States, and Grid #2,411 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 45.05 | 13 | 38 | 53 | 74 | 47 |
| Butterfly Network, Inc. | 51.18 | 7 | 68 | 77 | 54 | 50 |
| Palvella Therapeutics, Inc. | 41.85 | 8 | 13 | 76 | 50 | 62 |
| Vir Biotechnology, Inc. | 49.21 | 31 | 24 | 85 | 57 | 50 |
| AMN Healthcare Services, Inc. | 63.92 | 64 | 49 | 98 | 52 | 56 |
| Schrödinger, Inc. | 42.47 | 13 | 32 | 70 | 52 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -33.94 |
| P/B ratio | 5.26 |
EEarnings
| Trailing EPS | ₹-33.15 |
| Forward EPS | ₹-54.65 |
NNitro
| Price | 1125.21 |
| 52-week high | 1915.14 |
| 52-week low | 930.10 |
| Fall from 52-week high | 41.2% |
TTorque
| Return on equity (ROE) | -19.66% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.98 |
| Market cap | ₹16,031 Cr |
| Insider holding | 0.63% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Trevi Therapeutics, Inc.'s PosiPenta score?
Trevi Therapeutics, Inc.'s PosiPenta is 45.05 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Trevi Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Trevi Therapeutics, Inc. is Grid #381 of 836 in the Healthcare sector in United States, and Grid #2,411 of 3,999 in United States.
Which PosiPenta pillar is strongest for Trevi Therapeutics, Inc.?
Torque (durability), with a score of 74 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Trevi Therapeutics, Inc.?
Price (valuation), with a score of 13 out of 100: much weaker than most similar companies.
Has Trevi Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.06 points, from 41.99 to 45.05.
PositoAI is for research and education only and is not investment advice.